Drew Provan
- Hematology top 0.05%
- Platelet Disorders and Treatments 72
- Blood groups and transfusion 51
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Pathology and Forensic Medicine top 0.5%
- Autoimmune Bullous Skin Diseases 26
- Nephrology top 1%
- Renal Diseases and Glomerulopathies 12
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 9
-
- Blood properties and coagulation 15
- Co-authors
- Roberto StasiAdrian C. NewlandJames B. BusselNichola CooperBertrand GodeauDouglas B. CinesMarc MichelSergio Amadori
- Journals
- British Journal of Haematology (13 papers)Blood (13 papers)European Journal Of Haematology (5 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Drew Provan
101 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 5.1k
- Genetics 1.3k
- Pathology and Forensic Medicine 1.4k
- Nephrology 500
- Immunology 813
Countries citing papers authored by Drew Provan
This map shows the geographic impact of Drew Provan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Provan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Provan more than expected).
Fields of papers citing papers by Drew Provan
This network shows the impact of papers produced by Drew Provan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Provan. The network helps show where Drew Provan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Drew Provan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 6 | |
| 9 | 2017 | 14 | |
| 10 | 2016 | 8 | |
| 11 | 2015 | 67 | |
| 12 | 2013 | 14 | |
| 13 | 2010 | 70 | |
| 14 | 2008 | 52 | |
| 15 | 2007 | 124 | |
| 16 | Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpurabreakdown → | 2007 | 565 |
| 17 | 2007 | 100 | |
| 18 | 2007 | 57 | |
| 19 | 2006 | 163 | |
| 20 | 1997 | 37 |
About Drew Provan
Drew Provan is a scholar working on Hematology, Genetics and Nephrology, having authored 107 papers that have together received 6.2k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (72 papers), Blood groups and transfusion (51 papers), Autoimmune Bullous Skin Diseases (26 papers), Blood properties and coagulation (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Renal Diseases and Glomerulopathies (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). The work is most often cited by research in Hematology (5.1k citations), Genetics (1.3k citations) and Pathology and Forensic Medicine (1.4k citations). Drew Provan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Roberto Stasi, Adrian C. Newland, James B. Bussel, Nichola Cooper, Bertrand Godeau, Douglas B. Cines, Marc Michel, Sergio Amadori, Donald M. Arnold and Francesco Rodeghiero. Their work appears in journals such as British Journal of Haematology, Blood, European Journal Of Haematology, Haematologica and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.